Jet Capital Investors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-481
Closed -$15.7K 53
2015
Q1
$16K Buy
+481
New +$15.3K ﹤0.01% 58
2014
Q4
Sell
-3,622,440
Closed -$102M 59
2014
Q3
$102M Buy
3,622,440
+979,476
+37% +$27.5M 3.75% 4
2014
Q2
$74.4M Buy
2,642,964
+1,238,450
+88% +$35.3M 3.35% 9
2014
Q1
$42.8M Buy
+1,404,514
New +$41.9M 2.87% 11
2013
Q3
Sell
-1,000,089
Closed -$26.6M 52
2013
Q2
$26.6M Buy
+1,000,089
New +$27.6M 1.89% 20

Other funds holding PFE

Jet Capital Investors's PFE Position: Q2 2015 in Review

Jet Capital Investors sold out of Pfizer (PFE) in Q2 2015, closing a stake of 481 shares — an estimated $15.7K sold.

Jet Capital Investors first reported a position in PFE in Q2 2013 and held it in 5 quarters. The position peaked at $102M in Q3 2014. 1,887 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

  • Jet Capital Investors reported no remaining Pfizer position as of Q2 2015 after selling out during the quarter.
  • Jet Capital Investors sold 481 Pfizer shares in Q2 2015, an estimated $15.7K.
  • Jet Capital Investors first reported a position in Pfizer in Q2 2013 and held it in 5 quarters.
  • Jet Capital Investors's Pfizer position peaked at $102M in Q3 2014.
  • 1,887 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Jet Capital Investors's 13F filing for Q2 2015, filed 14 Aug 2015.